An observational cohort study to evaluate the impact of the tenofovir-based single tablet regimens on adherence, quality of life and cost-effectiveness in HIV-1 infected patients (GUESS) First published 08/03/2016 Last updated 01/04/2024 EU PAS number:EUPAS12725 Study Finalised